NexImmune, Inc.
NEXIDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001538210
NexImmune, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 13 institutions reported holding it in 13F filings for Q2 2024, worth $408.6K in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding NexImmune, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 31 | 32 | +1 |
| Shares | 5.78M | 4.45M | −1.32M (−22.9%) |
| Value | $2.20M | $1.26M | −$944.1K (−42.9%) |
New holders (5)
Institutions that held NexImmune, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 44,969 | $12.7K | 0.00% |
| HRT Financial LP | 41,958 | $11.0K | 0.00% |
| Two Sigma Securities, LLC | 23,732 | $6.69K | 0.00% |
| Susquehanna International Group, LLP | 11,014 | $3.07K | 0.00% |
| Royal Bank of Canada | 510 | $0 | 0.00% |
Sold out (4)
Institutions that held NexImmune, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Citigroup Inc | 799,170 | $303.7K |
| Sawtooth Solutions, LLC | 24,700 | $9.39K |
| BBR Partners, LLC | 20,000 | $7.60K |
| Bank of America Corp | 387 | $147 |